Skip to form

Join the RhoTM Waitlist

Osteoporosis is a prevalent disease with 1 in 3 women and 1 in 5 men suffering an osteoporotic fracture in their lifetime. These fractures are costly and often avoidable if appropriate interventions are initiated early. Rho gives radiologists the ability to better predict the likelihood of low BMD from a routine x-ray.

RhoTM is a Health Canada licensed and FDA authorized AI-driven software medical device intended to opportunistically screen x-rays in patients 50 years and older for low BMD. Rho’s findings can be included in your report with a simple macro. Rho can use 80% of x-rays performed including: chest, thoracic spine, lumbar spine, pelvis, knee and hand x-rays. Patients identified at increased risk of low BMD should receive a clinical fracture risk assessment. Many of those patients will return to your centre for DXA resulting in improved operational efficiency and increased revenue. That’s right - an AI system that actually provides value to radiologists and patients!

Our initial pilots show that a good proportion of patients who have low BMD are being further evaluated with DXA. Please complete the form below so we can assess if you are likely to benefit from adopting Rho and we will be in touch to discuss how your institution can partner with 16 Bit to improve population bone health.
Do you have a single PACS?*
On a scale of 1-10 how full is your DXA capacity?*
On a scale of 1-10 how much would you like to increase your DXA volume?*
What are the biggest limitations to you capitalizing on increased DXA referrals? Select all that apply.
We have the necessary IT resources to provision an on-premise linux-based server (existing or new hardware) to run Rho*